Published in Neurology on November 27, 2001
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol (2011) 1.25
Successful treatment of CANOMAD with IVIg and rituximab. J Neurol (2013) 0.87
Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy. Ann Indian Acad Neurol (2011) 0.84
Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature. J Neurol (2014) 0.82
Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study. J Neurol (2015) 0.76
Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology (2010) 2.29
Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain (2005) 2.25
[Progressive, ascending neurological impairment: a spinal epidural abscess that presents as Guillain-Barré syndrome]. Ned Tijdschr Geneeskd (2008) 2.15
Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2008) 2.03
Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.88
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology (2010) 1.80
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology (2010) 1.77
Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology (2010) 1.76
Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. Neurology (1996) 1.74
Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology (2010) 1.72
[Sensory disturbances caused by multivitamin preparations]. Ned Tijdschr Geneeskd (2005) 1.71
Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. J Clin Microbiol (2000) 1.70
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Sjögren's syndrome in patients with chronic idiopathic axonal polyneuropathy. J Neurol Neurosurg Psychiatry (1997) 1.54
Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology (2000) 1.54
Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barré or Miller Fisher syndrome. Appl Environ Microbiol (2000) 1.52
Inclusion of the transcervical approach in the video-assisted thoracoscopic extended thymectomy (BATET) for myasthenia gravis: a prospective trial. Surg Endosc (2007) 1.50
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun (2002) 1.48
The occurrence of Guillain-Barre syndrome within families. Neurology (2004) 1.48
Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol (2001) 1.47
Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology (2002) 1.40
Three families with polyneuropathy associated with monoclonal gammopathy. Arch Neurol (2000) 1.39
Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology (2004) 1.37
Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology (2005) 1.35
The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord (2006) 1.33
Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology (2005) 1.26
Surgery in adults with tethered cord syndrome: outcome study with independent clinical review. J Neurosurg (2001) 1.25
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Eur J Clin Microbiol Infect Dis (2012) 1.24
Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord (2008) 1.15
Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (2002) 1.14
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology (2005) 1.14
Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology (2000) 1.14
Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol (2000) 1.12
Lifetime occupation, education, smoking, and risk of ALS. Neurology (2007) 1.12
Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology (2011) 1.11
Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst (2010) 1.11
Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain (2003) 1.10
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain (2002) 1.10
Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve (2000) 1.08
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol (1999) 1.07
New hope for patients with pure lower motor neuron syndromes. J Neurol Neurosurg Psychiatry (1999) 1.07
Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients. Brain (1997) 1.05
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome. Neurology (2005) 1.04
Infections and course of disease in mild forms of Guillain-Barré syndrome. Neurology (2002) 1.03
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Infect Immun (2001) 1.03
Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao. Neurology (2001) 1.03
Filamin A mutation, a common cause for periventricular heterotopia, aneurysms and cardiac defects. J Neurol Neurosurg Psychiatry (2009) 1.01
Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms. Neurology (2003) 1.01
Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits. J Neuroimmunol (2000) 1.01
Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside. Ann Neurol (2000) 0.99
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome. J Neuroimmunol (2002) 0.98
Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Neurology (1999) 0.98
A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis. J Neuroimmunol (2000) 0.98
Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology (1997) 0.97
Binocular saccadic eye movements in multiple sclerosis. J Neurol Sci (1997) 0.97
Demonstration of nondeterministic quantum logic operations using linear optical elements. Phys Rev Lett (2002) 0.96
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.96
Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res (2004) 0.95
Recognizing Guillain-Barre syndrome in preschool children. Neurology (2011) 0.95
Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma. J Neurol Neurosurg Psychiatry (2003) 0.95
Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol (1995) 0.95
PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J Interferon Res (1993) 0.95
Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J Neurol Neurosurg Psychiatry (2002) 0.94
Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry (2006) 0.93
Response to exercise of patients with idiopathic hyper-CK-emia. Muscle Nerve (2002) 0.93
Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale. Neuromuscul Disord (2007) 0.93
Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet (2008) 0.93
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. Neurology (2000) 0.91
Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study. Neurology (2010) 0.90
Biomarker dynamics: estimating infection rates from serological data. Stat Med (2012) 0.90
Rituximab for polyneuropathy with IgM monoclonal gammopathy. J Neurol Neurosurg Psychiatry (2009) 0.89
Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology (2005) 0.89
Tryps after adventurous trips. Neth J Med (2010) 0.88
Medullary cone movement in subjects with a normal spinal cord and in patients with a tethered spinal cord. Radiology (2001) 0.88
Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology (2009) 0.88
Relationship between ischemia and neuropathy. Eur Neurol (2000) 0.87
Genetic heterogeneity in Miyoshi-type distal muscular dystrophy. Neuromuscul Disord (1998) 0.86
Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology (2006) 0.86
Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience (2008) 0.86
Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study. Brain (1997) 0.85
Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis--confirmation in two large cohorts. Rheumatology (Oxford) (2008) 0.85
Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve (2001) 0.84
Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups. J Infect Dis (1997) 0.83
Quality of life in patients with axonal polyneuropathy. J Neurol (2000) 0.83
Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy. Acta Neuropathol (2000) 0.82
Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clin Microbiol Infect (2007) 0.82